Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product Type Segment | Glucose Dehydrogenase (GDH) Strips, Glucose Oxidase (GOx) Strips, Others |
| Technology Segment | Wicking Technology, Electrochemical Technology, Optical Technology |
| Application Segment | Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others |
|---|---|
| End User Segment | Hospitals & Clinics, Home Care Settings, Laboratories, Others |
| Distribution Channel Segment | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| Regions & Countries |
|
Increasing global diabetes prevalence drives demand for blood glucose test strips Rising awareness about diabetes management boosts market growth Technological advancements enhance test strip accuracy and usability
High cost of test strips limits affordability for many patients Growing adoption of continuous glucose monitoring (CGM) reduces demand
Increasing adoption of smart and Bluetooth-enabled blood glucose test strips Rising demand for eco-friendly and biodegradable test strips
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
The blood glucose test strip market is highly competitive, with several global and regional players striving for market share. Key companies in this space focus on product innovation, strategic partnerships, and mergers & acquisitions to maintain a competitive edge. Major players such as Roche Diagnostics, Abbott Laboratories, LifeScan, Inc., and Ascensia Diabetes Care dominate the market due to their strong distribution networks and continuous technological advancements.
In December 2020, Aptar CSP Technologies extended its capacity for manufacturing numerous configurations of its 3-Phase Activ-PolymerTM technology to support augmented demand for diagnostic test kit protection solutions. 3-Phase Activ-PolymerTM technology delivers a broad spectrum of custom-engineered protection in a variety of configurations. Proven solutions for the diagnostics market include the company's Activ-VialTM, which can be used to house swabs or test strips, and Activ-FilmTM and active molded components that can be seamlessly integrated into kit components or packaging. https://csptechnologies.com/2020/12/16/aptar-csp-increases-capacity/ In October 2020, Airnov launched a HAT IN vial to protect diagnostic and nutraceutical products. The vial utilizes Airnov's advanced desiccant polymer (ADP) technology integrated into the vial with the moisture adsorption properties of desiccants to create a vial lining for moisture-sensitive products such as diagnostic test strips. https://manufacturingchemist.com/hat-in-vial-with-integrated-adp-insert-adds-new-capabilities-to-airnov-s-desiccant-vials-170613
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Abbott Laboratories | ••• | ••• | ••• | ••• |
| F. Hoffmann-La Roche Ltd. | ••• | ••• | ••• | ••• |
| Ascensia Diabetes Care | ••• | ••• | ••• | ••• |
| LifeScan Inc. | ••• | ••• | ••• | ••• |
| AgaMatrix Inc. | ••• | ••• | ••• | ••• |
| Arkray Inc. | ••• | ••• | ••• | ••• |
| B. Braun Melsungen AG | ••• | ••• | ••• | ••• |
| Others | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to Cognitive Market Research, the global Blood glucose test strip market size will be USD 24624.5 million in 2025. It will expand at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2033.
The Blood glucose test strips are disposable, small, and thin strips used in conjunction with glucose meters to measure blood sugar levels. These strips contain chemicals that react with the glucose in a blood sample, producing an electrical signal that the meter translates into a glucose reading. They are widely used by diabetic patients for self-monitoring of blood glucose (SMBG), allowing for better disease management and timely medical interventions. The blood glucose test strip market is experiencing significant growth, driven by the rising global prevalence of diabetes. Increasing awareness about diabetes management, coupled with technological advancements in glucose monitoring devices, is fueling market expansion. The growing elderly population, who are more susceptible to diabetes, also contributes to the demand for test strips.
In February 2021, Quidel, a major American manufacturer of diagnostic healthcare products, integrated active packaging technology to protect from moisture and other environmental conditions that could otherwise impact accuracy. https://ir.quidelortho.com/news/news-release-details/2021/Quidel-Opens-New-Manufacturing-Facility-to-Mass-Produce-QuickVue-Rapid-Antigen-Tests-for-COVID-19/default.aspx
Conclusion
★ Reviews
Rate this report
| Product Type | Glucose Dehydrogenase (GDH) Strips, Glucose Oxidase (GOx) Strips, Others |
| Technology | Wicking Technology, Electrochemical Technology, Optical Technology |
| Application | Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others |
| End User | Hospitals & Clinics, Home Care Settings, Laboratories, Others |
| Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| List of Competitors | Abbott Laboratories, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care, LifeScan Inc., AgaMatrix Inc., Arkray Inc., B. Braun Melsungen AG, Others |
Additional data which we are providing for Blood Glucose Test Strip market
Consumer Behavior & Usage Patterns
Frequency of self-monitoring among diabetic patients (Type 1 vs. Type 2).
Price sensitivity and purchasing preferences (bulk packs, subscription models).
Role of insurance coverage and reimbursement in adoption.
Shift toward digital integration with smartphone-connected meters.
Product Innovation & Technology Trends
Development of ultra-thin, less painful, and faster-reading strips.
Advancement in biosensor chemistry for higher accuracy.
Integration with continuous glucose monitoring (CGM) systems.
Eco-friendly and biodegradable test strip innovations.
Distribution & Sales Channel Dynamics
Growth of e-commerce and direct-to-patient delivery models.
Role of hospital pharmacies, retail chains, and specialty clinics.
Increasing partnerships with online healthcare platforms.
Regional variance in availability due to regulatory constraints.
Regulatory & Compliance Landscape
FDA, CE, and ISO certification requirements for accuracy and safety.
Country-specific reimbursement policies influencing affordability.
Regulatory push toward digital monitoring & patient data security.
Standards for interoperability with glucometers and mobile apps.
Future Opportunities & Growth Drivers
Rising global diabetes prevalence
Expanding digital health ecosystem (apps, telehealth integration).
Opportunities in emerging markets with growing urbanization.
Corporate wellness programs & preventive healthcare adoption.
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Global Blood Glucose Test Strip Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Global Blood Glucose Test Strip Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the global blood glucose test strip market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.